Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.19 USD
Change Today -0.02 / -0.62%
Volume 12.0K
RIBT On Other Exchanges
Symbol
Exchange
NASDAQ CM
Munich
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

ricebran technologies (RIBT) Snapshot

Open
$3.20
Previous Close
$3.21
Day High
$3.25
Day Low
$3.13
52 Week High
08/29/14 - $6.90
52 Week Low
01/29/15 - $2.50
Market Cap
29.9M
Average Volume 10 Days
5.1K
EPS TTM
$-3.92
Shares Outstanding
9.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RICEBRAN TECHNOLOGIES (RIBT)

Related News

No related news articles were found.

ricebran technologies (RIBT) Related Businessweek News

No Related Businessweek News Found

ricebran technologies (RIBT) Details

RiceBran Technologies engages in processing and marketing of healthy, natural, and nutrient dense products that are derived from raw rice. It manufactures and distributes stabilized rice bran (SRB) in various granulations together with other products and derivatives; and extracts crude rice bran oil, and defatted rice bran from rice bran, animal nutrition products, human food and animal nutrition product derivatives and co-products. The company produces RiSolubles, a nutritious carbohydrate and lipid rich fraction of SRB; RiFiber, a fiber rich derivative of SRB; RiBalance, a rice bran nutritional package derived from further processing of SRB; distilled fatty acids, a raw material for the detergent industry; and rice lecithin, which has application in human nutrition, animal nutrition, and industry. It serves manufacturers, wholesalers, and retailers of natural food, functional food, cosmetic, and animal nutrition products in the United States, Brazil, and internationally. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was incorporated in 1998 and is headquartered in Scottsdale, Arizona.

295 Employees
Last Reported Date: 03/31/15
Founded in 1998

ricebran technologies (RIBT) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $383.7K
Chief Financial Officer, Chief Accounting Off...
Total Annual Compensation: $255.0K
Senior Vice President of Operations and R&D
Total Annual Compensation: $174.0K
Senior Vice President of Sales & Marketing an...
Total Annual Compensation: $198.5K
Compensation as of Fiscal Year 2014.

ricebran technologies (RIBT) Key Developments

Ricebran Technologies Approves Election of Marco V. Galante as Director

RiceBran Technologies announced that at its AGM held on June 24, 2015, the shareholders approved election of Marco V. Galante as director of the company.

RiceBran Technologies Reports Positive Results for UK Study of RiFiber in Reducing Benign Tumor Cells in Genetic Mouse Model

RiceBran Technologies reported positive results from a study performed by a team of researchers from the University of Leicester, Loughborough University, Leicester, UK, and Glenfield Hospital, Leicester. The study results were accepted for publication on May 29 in Molecular Nutrition & Food Research. Working with RiceBran Technologies' RiFiber rice bran derivative, which is high in insoluble dietary fiber, the UK study demonstrates a dose-dependent reduction in intestinal adenomas in ApcMin mice that consumed a diet containing RiFiber. ApcMin mice possess a heritable Apc gene mutation which is responsible for adenoma mutation and serve as a model for colorectal carcinogenesis. The UK scientists showed that consumption of RiFiber in ApcMin mice was associated with changes in metabolic pathways as evidenced by metabolic profiling. Moreover, proteomic analysis identified adiponectin as a component that was significantly elevated in the RiFiber fed mice. Elevated levels of adiponectin have previously been associated with a suppression of carcinogenesis in ApcMin mice, and with skeletal muscle mass increase and fat cell reduction in human studies.

RiceBran Technologies Enters Senior Secured Revolving Credit Facility Agreement

RiceBran Technologies entered into a Loan, Guarantor and Security Agreement with Full Circle Capital Corporation as agent and lender and certain of Company's subsidiaries as joint and several guarantors, pursuant to which Company was extended a senior secured credit facility comprised of a $3,500,000 revolving loan and an initial $2,500,000 term loan, which term loan can be increased by up to $2,000,000 within 24 months. The funds will be used for general corporate purposes and to provide working capital to facilitate future growth. Under the Credit Agreement, the Company may borrow under the revolving loan up to the lesser of the Borrowing Base and the revolving loan commitment of $3,500,000. The loan matures on June 1, 2018, subject to two one-year maturity extensions. This credit facility is subject to certain financial and non-financial covenants. The loan bears interest at a variable interest rate based on LIBOR, with a 0.75% floor and 1.25% cap, plus 10.75% per annum, and the Company will pay certain fees, as set forth in the Credit Agreement. As part of the agreement, the Lender received warrants to purchase a total of 300,000 shares of Company's common stock at an exercise price per share of $5.25, exercisable over a five-year term. The loan is guaranteed by the Subsidiary Guarantors and is secured by substantially all of the assets of the Company and Subsidiary Guarantors other than 50% of the Company's interest in RBT-Pro, LLC and Nutra SA, LLC. The Credit Agreement imposes certain restrictions on the Company and Guarantors, including on its ability to (i) incur indebtedness, (ii) incur liens, (iii) make investments, (iv) permit a Change in Control (as defined in the Credit Agreement) or dispose of all or substantially all of its assets, (v) make capital expenditures not in the ordinary course of its business, (vi) issue or distribute capital stock, (vii) make distributions to its shareholders, (viii) engage in any line of business other than the business engaged in on the date of the Credit Agreement and businesses reasonably related thereto, and (ix) enter into transactions with any affiliates. Each of these restrictions is subject to certain exceptions, as specified in the Credit Agreement.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RIBT:US $3.19 USD -0.02

RIBT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RIBT.
View Industry Companies
 

Industry Analysis

RIBT

Industry Average

Valuation RIBT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RICEBRAN TECHNOLOGIES, please visit www.ricebrantech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.